NCT04163796

Brief Summary

People with higher level of spinal cord injury have limitations to using exoskeletal-assisted walking devices due to restrictions of trunk stability, functional use of the upper extremities and hand grip. With increasing sedentary time in wheelchairs, people with SCI have a high risk for developing secondary complications. A powered wheelchair has recently been developed for use in persons with spinal cord injury that provides a solution for placing the user in an upright, standing position while maintaining the overground mobility features of the powered wheelchair; providing the ability to engage in society in either a standing or seated position. The purpose of this study is to verify user performances of the upright powered wheelchair and to identify obstacles that are difficult, or prevent use. Additionally, the option to have upright posture throughout the day may have the potential to improve some of the secondary medical conditions associated with the extreme sedentary lifestyle. This study will determine change from baseline after 12 weeks of use for safety, tolerance, medical, physical and quality of life outcomes. The intervention will consist of 3.5 hours per session, 3 times per week for 12 weeks. During each session, participants will be asked to stand at least 5 minutes during every 15 minutes. To our knowledge, there is no existing empirical data on intermittent standing during the day in persons with higher levels of SCI who cannot otherwise stand and whether this approach will improve health related outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
1.3 years until next milestone

First Posted

Study publicly available on registry

November 15, 2019

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

January 8, 2024

Status Verified

January 1, 2024

Enrollment Period

5.4 years

First QC Date

June 18, 2018

Last Update Submit

January 4, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Wheelchair mobility skills - RPE

    Participants will be requested to perform a rating of perceived exertion (RPE).

    Training Period - 36 Sessions up to 12 weeks

  • Wheelchair mobility skills - FIM

    Participants will be requested to perform a rating Functional Independence Measurement (FIM) for each UPnRIDE activity.

    Training Period - 36 Sessions up to 12 weeks

  • Activities Daily Living Course - RPE

    Participants will be requested to perform a rating of perceived exertion (RPE) during the Activities Daily Living Course (ADLC).

    Training Period - 36 Sessions up to 12 weeks

  • Activities Daily Living Course - FIM

    Participants will be requested to perform a rating Functional Independence Measurement (FIM) during the Activities Daily Living Course (ADLC).

    Training Period - 36 Sessions up to 12 weeks

Secondary Outcomes (14)

  • Postural orthostatic hypotension blood pressure tolerance test (OH BP)

    Evaluations - Baseline/After session 18 (up to 6 weeks) /After session 36 (up to 12 weeks)

  • Pulmonary function tests - Spirometry

    Evaluations - Baseline/After session 18 (up to 6 weeks) /After session 36 (up to 12 weeks)

  • Pulmonary function tests - Static Lung Volumes

    Evaluations - Baseline/After session 18 (up to 6 weeks) /After session 36 (up to 12 weeks)

  • Pulmonary function tests - Breathing Pattern

    Evaluations - Baseline/After session 18 (up to 6 weeks) /After session 36 (up to 12 weeks)

  • Inflammatory biomarkers

    Evaluations - Baseline/After session 18 (up to 6 weeks) /After session 36 (up to 12 weeks)

  • +9 more secondary outcomes

Study Arms (1)

UPnRIDE Training

EXPERIMENTAL

During each session, heart rate (HR), blood pressure (BP), total session time, time in standing posture, count of sit-to-stand positioning, total distance of overground movement, and rating of perceived exertion (Borg scale) for mobility skills will be monitored. At all study visits during the training period, participants will be asked to answer general health questions about the occurrence of any pressure ulcers or infections.

Device: UPnRIDE power wheelchair

Interventions

The intervention will consist of approximately 3.5 hours per session, 3 times per week over 12 weeks. During each 3.5-hour session, subjects will be asked to stand at least 5 minutes during every 15 minutes or more as tolerated. One time each session, participants will be asked to perform the Activities of Daily Living course.

UPnRIDE Training

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Power wheelchair user as a primary means of mobility;
  • years old;
  • ≥1 year after SCI;
  • Height of 160 to 190 cm;
  • Weight of \<100 kg; and
  • Able to sign informed consent.

You may not qualify if:

  • Able to ambulate with or without an assistive device or physical assistance greater than 4 consecutive steps;
  • Any pressure ulcer at any body location that is deemed to be contraindicated for a power wheelchair or standing frame by the study physician;
  • Severe spasticity (Ashworth 4) or uncontrolled clonus;
  • Psychiatric or cognitive status that may interfere with the ability to follow instruction to use the device; and
  • Pregnant or lactating women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spinal Cord Damage Research Center

The Bronx, New York, 10468, United States

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • EunKyoung Hong, PhD

    Bronx VMRF

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoctoral Researcher

Study Record Dates

First Submitted

June 18, 2018

First Posted

November 15, 2019

Study Start

August 1, 2018

Primary Completion

December 30, 2023

Study Completion

December 30, 2023

Last Updated

January 8, 2024

Record last verified: 2024-01

Locations